Adynxx Inc. (ADYX)

3.61  -2.33 (-39.23%)

After market: 3.65 +0.04 (+1.11%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Adynxx Inc.

NASDAQ:ADYX (6/12/2019, 7:08:49 PM)

After market: 3.65 +0.04 (+1.11%)

3.61

-2.33 (-39.23%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap3.01M
Shares
PEN/A
Fwd PEN/A
Dividend Yield0%
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

ADYX Daily chart

Company Profile

Adynxx Inc. is a clinical-stage biopharmaceutical company. It is focused on therapeutics for the treatment of pain and inflammatory diseases. Adynxx Inc., formerly known as Alliqua BioMedical Inc., is based in San Francisco, United States.

Company Info

Adynxx Inc.

2150 CABOT BLVD WEST SUITE B

LANGHORNE PA 19047

P: 215-702-8550

CEO: David Johnson

ADYX News

News Image4 years ago - BusinessInsiderAdynxx Reports Third Quarter 2019 Financial Results
News Image4 years ago - Adynxx, Inc.Adynxx Reports Third Quarter 2019 Financial Results
News Image5 years ago - Adynxx, Inc.Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic

Award of More than $600K Will Support Advancement of AYX2 for Chronic Pain to IND-Enabling Studies

News Image5 years ago - Seeking AlphaAdynxx readies $15M stock offering

Adynxx (OTC:ADYX) has filed a preliminary prospectus for a $15M public offering of common stock or pre-funded warrants. Price, volume and terms have yet to be announced.

News Image5 years ago - Adynxx, Inc.Adynxx Reports Second Quarter 2019 Financial Results
News Image5 years ago - MarketwatchNasdaq slumps more than 200 points as Dow is saddled with 540-point decline

COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information.

ADYX Twits

Here you can normally see the latest stock twits on ADYX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example